Microvast Has Been Sued Once Already. Now Eight Law Firms Want You to Call.

The press release from Wolf Haldenstein says shareholders who lost money in Microvast Holdings should contact the firm immediately. The press release from Rosen Law Firm says the same thing, sent the same day. Frank R. Cruz, SueWallSt, Bernstein Liebhard, Howard G. Smith, Bronstein Gewirtz, Levi & Korsinsky, Schall Brown & Schwartz - at least eight separate law firms have all sent nearly identical messages in the past two weeks, each one urging investors to call now.

That was weird. The basic point is that these firms are not yet representing you. They are competing to be the ones who eventually do. The urgency you're supposed to feel is real, but it is also their product.

The actual Microvast story is a cascade of promises that didn't match what showed up at the factory gate. The class action complaint, filed in the Southern District of Texas as Graham v. Microvast Holdings, Inc., covers purchases between April 1, 2025 and March 16, 2026. The allegation has two main parts: management overstated its ability to hit gross margin targets, and it overstated how soon it could finish expanding its Huzhou, China battery factory.

Then the calendar did what calendars do when operations don't go to plan. On June 25, 2025, a short seller called Grizzly Research published a report accusing Microvast of "fabricating a significant part of its business and capabilities," including overstating activity at the Huzhou plant and inflating the value of commercial partnerships. The stock fell roughly 10%. On August 1, the CFO Carl Schultz quit after three months on the job - the kind of departure that usually means someone looked under the hood and didn't like what they found. Another 10% drop. On November 10, Microvast admitted the Huzhou Phase 3.2 expansion wouldn't produce batteries until Q1 2026, even though management had repeatedly told investors it would be online by Q4 2025. Another 10%. Then came the big one on March 16, 2026: gross margin collapsed to roughly 1% in Q4 2025, down from about 36% the prior year, and revenue of $96.5 million came in far below the $136.4 million consensus estimate. The stock fell 34%, closing at $1.52.

The margin collapse is the headline number. It matters because it suggests the business economics that Microvast was selling to investors - and that the stock price was pricing in - were not real. The company attributed the margin implosion to inventory impairment charges on "specialized ESS components," which is finance for "we built things nobody bought and now we have to write them down." Revenue fell 15% year-over-year, which the company blamed on regulatory shifts in South Korea and customer delays in Europe.

If you want to understand how severe this is, Q1 2026 was even worse. Revenue dropped 48% to $60.6 million. Adjusted EBITDA - a rough cash-earnings proxy that strips out interest, taxes, and depreciation - flipped to a $5.5 million loss. And Deloitte, Microvast's auditor, attached a going concern warning to the financials, which is the formal accounting way of saying there is substantial doubt the company can stay in business. The chief accounting officer Eric Garcia departed in late May, then a separate law firm, Halper Sadeh, announced it was investigating whether officers and directors breached their fiduciary duties. That's the kind of personnel movement that happens when a company's financial plumbing starts to look like a crime scene.

As of today, the stock is trading at roughly $0.82. The case that matters most for the current lawsuit - the class period ending March 16, 2026 - was priced in by then. The Q1 2026 numbers and the continuing decline after that are outside the class period, which means they add context but not legal standing for this particular round of suits.

Here is the part the press releases don't say. Microvast has been here before.

There is an existing class action, Schelling v. Microvast Holdings, Inc., filed in December 2023 and still pending in the Southern District of Texas. That one is about a $200 million grant from the U.S. Department of Energy that Microvast announced it had received in October 2022, only for Reuters to report in May 2023 that the DOE would not award it after all. The complaint alleged Microvast knew it wouldn't get the grant months before the public found out. As of August 2025, a federal judge allowed most of those claims to proceed.

So the company is already in a securities lawsuit over making a false statement about a government check that didn't arrive. And now it is in another one over margins, factory timelines, and a short seller who says the whole thing is fabricated. The second lawsuit didn't start from scratch. It started the way these things always start: with a short report or an earnings miss that breaks the story, followed by a swarm of law firms filing within days of each other.

The class action machine is a standardized business. The firms that file first are positioning for a court appointment as lead counsel, which comes with a larger share of the fee - typically 10% to 30% of any eventual settlement or judgment, paid by the defendant and approved by the judge. The lead plaintiff deadline in this case is September 21, 2026, and that is the "immediately" the press releases are talking about. If you bought during the class period and suffered a loss, you can apply to be the lead plaintiff who represents the class. Most people don't bother. Most of these cases end in settlements where class members receive a distribution without ever appearing in court.

The competition among the firms is real, but it is a competition among lawyers, not a competition for your benefit. They are not offering you free legal advice. They are filing a complaint and running a press release to build their track record and capture the lead counsel slot. The "you pay nothing unless we win" promise in every one of these ads is true, but the real question is whether there is anything to win.

The substantive allegations here - overstated margins, delayed expansion timelines, a CFO who fled after 90 days - are the ordinary currency of securities fraud cases. The harder question is whether Microvast's statements were intentionally misleading or just optimistic in the way that a battery manufacturer trying to fill a $2 billion factory would naturally be. The first lawsuit over the DOE grant had a cleaner factual spine: the company announced a grant, the government said no, the stock fell. This one is messier. Factory delays happen. Margins compress. The short seller's accusation of fabrication is a strong claim that a court will want to test.

The simplest model is this: Microvast is a battery company that is burning through its SPAC-era cash, struggling to convert factory capacity into profitable sales, and has now been sued twice for overstating its prospects. The stock is below a dollar. The auditor has flagged a going concern. The litigation machine has already assembled itself with eight firms running identical copy, and the first lawsuit is still pending.

What the press releases from Wolf Haldenstein and the seven other firms are selling you is not representation. They are selling you a filing date. If you're a shareholder who lost money, the September 21 lead plaintiff deadline is the only real date on the calendar. But the more useful thing to understand is that the company's credibility problem didn't start with the class period and won't end with a settlement. The question that will determine whether any of this matters is whether Microvast can ever produce the margins it has been promising for years. Until it does, the lawsuits keep coming, and the law firms keep running the same press release.